Setting the stage: current state of affairs and major challenges.
The global human immunodeficiency virus (HIV) pandemic reached staggering proportions over the past 2 decades, particularly in areas of sub-Saharan Africa and other developing countries. Tremendous increases in donor resources over the past decade have allowed for a rapid scale-up of antiretroviral treatment and greater access to basic care and prevention programs in countries worst affected by HIV infection and AIDS. These programs have had a tremendous impact on the lives of millions of individuals and have also created optimism and hope where previously there was despair. Major challenges remain in combating the current HIV pandemic with regard to access to treatment; efficiency, quality, and sustainability of current programs; and the scale-up of evidence-based, effective prevention strategies. The global health community and political leaders will need to overcome these challenges if a long-term effective response to the HIV pandemic is to be achieved.
Reynolds
Steven J
SJ
Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. sjr@jhmi.edu
Quinn
Thomas C
TC
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D017954:Africa South of the Sahara / Q000453:epidemiology; D003906:Developing Countries; D004196:Disease Outbreaks; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*; D006801:Humans; D007391:International Cooperation; D014376:Tuberculosis / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*
N Engl J Med. 2009 Apr 30;360(18):1815-26
19339714
MMWR Morb Mortal Wkly Rep. 2008 Aug 8;57(31):845-9
18685551
Lancet. 2004 Oct 16-22;364(9443):1428-34
15488218
N Engl J Med. 2008 Apr 10;358(15):1560-71
18337596
Lancet. 2008 Mar 1;371(9614):752-9
18313504
AIDS. 2008 Mar 12;22(5):617-24
18317003
PLoS Med. 2005 Nov;2(11):e298
16231970
Trop Med Int Health. 2008 Jul;13(7):870-9
18373510
N Engl J Med. 2008 Jul 10;359(2):119-29
18525035
N Engl J Med. 2010 Feb 4;362(5):427-39
20089951
AIDS Care. 2007 May;19(5):605-7
17505920
J Int Assoc Physicians AIDS Care (Chic). 2008 May-Jun;7(3):130-2
18441254
J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):208-12
15671807
AIDS. 2009 Jul 17;23(11):1397-404
19381076
Lancet. 2008 Jun 21;371(9630):2109-19
18572080
AIDS. 2009 Mar 27;23(6):697-700
19209067
Lancet. 2010 Mar 6;375(9717):824-33
20153888
AIDS. 2009 Jun 1;23(9):1127-34
19417582
Ann Intern Med. 2009 May 19;150(10):688-95
19349625
Lancet. 2006 Nov 4;368(9547):1587-94
17084759
J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):220-3
18520682
Lancet. 2007 Feb 24;369(9562):657-66
17321311
AIDS Patient Care STDS. 2008 Mar;22(3):173-4
18290750
Lancet. 2009 Jan 3;373(9657):48-57
19038438
AIDS. 2008 Oct 1;22(15):1971-7
18784460
PLoS One. 2009;4(3):e4997
19325707
J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):276-82
19194316
Am J Trop Med Hyg. 2005 Nov;73(5):926-33
16282305
Lancet. 2008 Jul 26;372(9635):300-13
18657709
PLoS Med. 2009 Apr 28;6(4):e1000066
19399157
Lancet. 2007 Feb 24;369(9562):643-56
17321310
N Engl J Med. 2000 Mar 30;342(13):921-9
10738050
J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):436-9
17019367
BMC Health Serv Res. 2009 Jan 09;9:5
19134202
JAMA. 2008 Aug 6;300(5):520-9
18677024